Academic Journal
Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
| العنوان: | Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 |
|---|---|
| المؤلفون: | Kisa, Adnan, Disease Collaborators, GBD Chronic Respiratory, Soriano, Joan B., Kendrick, Parkes J, Vos, Theo, Kisa, Sezer, Naghavi, Mohsen, Mokdad, Ali H. |
| المصدر: | 585–96 ; 8 ; The Lancet Respiratory Medicine |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | chronic respiratory diseases, lung diseases, lungesykdommer, global burden of disease, global sykdomsbyrde |
| الوصف: | Background Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma. In this study, we aimed to characterise the burden of chronic respiratory diseases globally, providing a comprehensive and up-to-date analysis on geographical and time trends from 1990 to 2017. Methods Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, we estimated the prevalence, morbidity, and mortality attributable to chronic respiratory diseases through an analysis of deaths, disability-adjusted life-years (DALYs), and years of life lost (YLL) by GBD super-region, from 1990 to 2017, stratified by age and sex. Specific diseases analysed included asthma, COPD, interstitial lung disease and pulmonary sarcoidosis, pneumoconiosis, and other chronic respiratory diseases. We also assessed the contribution of risk factors (smoking, second-hand smoke, ambient particulate matter and ozone pollution, household air pollution from solid fuels, and occupational risks) to chronic respiratory disease-attributable DALYs. Findings In 2017, 544·9 million people (95% uncertainty interval [UI] 506·9–584·8) worldwide had a chronic respiratory disease, representing an increase of 39·8% compared with 1990. Chronic respiratory disease prevalence showed wide variability across GBD super-regions, with the highest prevalence among both males and females in high-income regions, and the lowest prevalence in sub-Saharan Africa and south Asia. The age-sex-specific prevalence of each chronic respiratory disease in 2017 was also highly variable geographically. Chronic respiratory diseases were the third leading cause of death in 2017 (7·0% [95% UI 6·8–7·2] of all deaths), behind cardiovascular diseases and neoplasms. Deaths due to chronic respiratory diseases numbered 3 914 196 (95% UI 3 790 578–4 044 819) in 2017, an increase of 18·0% since 1990, while total DALYs increased by 13·3%. However, when ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| تدمد: | 2213-2600 |
| Relation: | Lancet Respir Med 2020; 8: 585–96; urn:issn:2213-2600; https://hdl.handle.net/11250/3051447; https://doi.org/10.1016/S2213-2600(20)30105-3; cristin:1814949 |
| DOI: | 10.1016/S2213-2600(20)30105-3 |
| الاتاحة: | https://hdl.handle.net/11250/3051447 https://doi.org/10.1016/S2213-2600(20)30105-3 |
| Rights: | Navngivelse 4.0 Internasjonal ; http://creativecommons.org/licenses/by/4.0/deed.no |
| رقم الانضمام: | edsbas.67EAAD8D |
| قاعدة البيانات: | BASE |
| تدمد: | 22132600 |
|---|---|
| DOI: | 10.1016/S2213-2600(20)30105-3 |